James Huang is a venture capital investor at Kleiner Perkins who spent over two decades as an operator in both big pharma and biotech startups before moving into investing, giving him hands-on experience that he draws on to coach portfolio companies on execution and scaling in complex healthcare systems. He specializes in cross-border U.S.-China biotech investments and frequently serves as executive chairman or CEO of portfolio companies and SPAC vehicles, positioning him as both capital provider and hands-on strategic leader in biotech build-outs. James Huang is a venture capital investor at Kleiner Perkins who spent over two decades as an operator in both big pharma and biotech startups before moving into investing, giving him hands-on experience that he draws on to coach portfolio companies on execution and scaling in complex healthcare systems. He specializes in cross-border U.S.-China biotech investments and frequently serves as executive chairman or CEO of portfolio companies and SPAC vehicles, positioning him as both capital provider and hands-on strategic leader in biotech build-outs.